The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Regulatory News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 344.00
Bid: 344.00
Ask: 346.00
Change: -6.00 (-1.71%)
Spread: 2.00 (0.581%)
Open: 346.00
High: 349.00
Low: 343.00
Prev. Close: 350.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

28 Apr 2017 13:40

RNS Number : 7219D
Hutchison China Meditech Limited
28 April 2017
 

Total Voting Rights

London: Friday, April 28, 2017: For information purposes, Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) hereby notifies the market that as at April 28, 2017, the issued share capital of Chi-Med consisted of 60,735,104 ordinary shares of US$1.00 each, with each share carrying one right to vote and with no shares held in treasury.

 

The above figure of 60,735,104 may be used by shareholders as the denominator for the calculations by which they could determine if they are required to notify their interest in, or a change to their interest in, Chi-Med under the Financial Conduct Authority's Disclosure Rules and Transparency Rules.

 

For illustrative purposes only, the 60,735,104 ordinary shares would be equivalent to 60,735,104 CREST depositary interests (each equating to one ordinary share) which are traded on AIM or, if the CREST depositary interests were converted in their entirety, equivalent to 121,470,208 American depositary shares (each equating to one-half of one ordinary share) which are traded on Nasdaq.

 

 

About Chi-Med

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

 

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001). For more information, please visit: www.chi-med.com.

 

 

CONTACTS

 

Investor Enquiries

Christian Hogg, CEO

+852 2121 8200

U.K. & International Media Enquiries

Anthony Carlisle, Citigate Dewe Rogerson

+44 7973 611 888 (Mobile)

anthony.carlisle@cdrconsultancy.co.uk

U.S. Based Media Enquiries

Brad Miles, BMC Communications

+1 (917) 570 7340 (Mobile)

bmiles@bmccommunications.com

Susan Duffy, BMC Communications

+1 (917) 499 8887 (Mobile)

sduffy@bmccommunications.com

Investor Relations

Matt Beck, The Trout Group

+1 (917) 415 1750 (Mobile)

mbeck@troutgroup.com

David Dible, Citigate Dewe Rogerson

+44 7967 566 919 (Mobile)

david.dible@citigatedr.co.uk

Panmure Gordon (UK) Limited

Richard Gray / Andrew Potts

+44 (20) 7886 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREAALPADAXEFF
Date   Source Headline
13th May 20157:00 amRNSFruquintinib results trigger payments from Lilly
30th Apr 20157:00 amRNSTotal Voting Rights
24th Apr 201512:40 pmRNSResult of AGM
22nd Apr 201511:23 amRNSDirector/PDMR Shareholding
16th Apr 20151:19 pmRNSDirector's Shareholding
13th Apr 20158:07 amRNSDirector's Shareholding
8th Apr 20158:18 amRNSDirectors' Shareholding
1st Apr 20153:48 pmRNSDirectors Shareholding
1st Apr 20152:32 pmRNSExercise of Options
30th Mar 20157:00 amRNSTrial of fruquintinib achieves primary endpoint
23rd Mar 20157:00 amRNSNotice of AGM
18th Mar 20157:08 amRNSNotification of Major Interest in Shares
6th Mar 20157:06 amRNSPatient enrolment completion for Phase II study
26th Feb 20157:00 amRNSFinal Results
29th Jan 20157:00 amRNSDistribution Agreement for Seroquel in China
26th Jan 20157:00 amRNSNotice of Results
31st Dec 20147:00 amRNSTotal Voting Rights
29th Dec 20147:00 amRNSBlocklisting Six Monthly Return
15th Dec 20147:00 amRNSInitiation of fruquintinib Phase III study
31st Oct 20147:03 amRNSTotal Voting Rights
7th Oct 20147:00 amRNSDrug R&D Update Briefing
1st Oct 20147:00 amRNSCo-promotion agreement with Merck Serono
19th Sep 20149:13 amRNSHolding(s) in Company
21st Aug 20147:00 amRNSPatient enrolment in Phase II study completed
13th Aug 20147:00 amRNSHMPL-004 Interim Analysis
29th Jul 20147:00 amRNSInterim Results
30th Jun 20147:00 amRNSBlocklisting Interim Review
30th Jun 20147:00 amRNSTotal Voting Rights
26th Jun 20147:00 amRNSNotice of Results
25th Jun 20147:00 amRNSChi-Med Refinancing of Existing Loan Facility
18th Jun 20147:00 amRNSStart of Phase I clinical trial with HMPL-523
5th Jun 20147:00 amRNSInitiation of fruquintinib Phase II study
4th Jun 20141:52 pmRNSDirector's Shareholding
3rd Jun 20143:23 pmRNSExercise of Options
30th May 20149:10 amRNSGains rights to six prescription drug products
23rd May 20147:00 amRNSInitiation of Phase II Study in Renal Cancer
22nd May 20147:00 amRNSPhase I data to be presented at ASCO
8th May 201411:54 amRNSResult of AGM
17th Apr 20147:00 amRNSChi-Med and Sinopharm Deal Approved
4th Apr 20147:00 amRNSInitiation of Phase II study in colorectal cancer
4th Apr 20147:00 amRNSPresentations at the 2014 AACR Annual Meeting
28th Mar 20147:00 amRNS2013 Annual Report and Notice of AGM
18th Feb 20147:00 amRNSFinal Results
13th Feb 20148:14 amRNSNotification of Major Interest in Shares
16th Jan 20147:00 amRNSNotice of Results
30th Dec 20137:00 amRNSBlocklisting Six Monthly Return
18th Dec 20139:02 amRNSSinopharm distribution joint venture in China
16th Oct 201311:58 amRNSDirector/PDMR Shareholding
9th Oct 20137:00 amRNSPayment From Janssen Pharmaceuticals
9th Oct 20137:00 amRNSLilly Deal for Fruquintinib

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.